November 21, 2024
At Crown Bioscience, we are constantly developing, evaluating, and utilizing innovative technologies, to serve the dynamic needs of your preclinical and translational studies. We provide end-to-end service to our customers, using the most advanced analysis and generate comprehensive data, utilizing machine intelligence to help you make better-informed decisions.
Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.
Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies
Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.
Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.
Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.
Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.
Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your studies needs.
Certified CRO services with NanoString GeoMx Digital Spatial Profiling
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-01-03
2023-03-20